首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Schizophrenia research

缩写:SCHIZOPHR RES

ISSN:0920-9964

e-ISSN:1573-2509

IF/分区:3.5/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引7146
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Chen Tengfei,Wang Shiyu,Sheng Longyu et al. Chen Tengfei et al.
Objective: Emerging evidence suggests that dysregulated neuroimmune pathways are implicated in schizophrenia (SCZ); however, the mechanisms connecting early-life inflammation to adult psychiatric outcomes remain inadequat...
Nazar Kuzo,Davide Gaspari,Fabio Carpi et al. Nazar Kuzo et al.
Objective: To investigate the pharmacokinetic correlates of clinical response to long acting injectable (LAI) antipsychotics in a naturalistic outpatient sample. ...
Siya Peng,Xiujuan Geng,Winky Wing Kee Huen et al. Siya Peng et al.
Introduction: Emerging evidence has implicated glymphatic dysfunction in schizophrenia-spectrum disorders (SSD), yet its role during early stages of the disease remains unclear. To clarify its involvement in pathophysiolo...
Kristina Ballestad Gundersen,Benjamin Arnfred,Nikolai Albert et al. Kristina Ballestad Gundersen et al.
Background: Evidence to guide treatment for schizotypal disorder is scarce, and clinical guidelines remain undeveloped. This systematic review synthesized current evidence on pharmacological and psychotherapeutic interven...
Luyu Zhang,Zhixin Zhang,Gregory P Strauss Luyu Zhang
Background: The generalized neurocognitive deficit is a core feature of schizophrenia (SZ). However, no current treatments have demonstrated satisfactory efficacy in remediating cognitive impairment in this population. Th...
Dmitry Senko,Marina Zavolskova,Olga Efimova et al. Dmitry Senko et al.
Schizophrenia and major depressive disorder are typically classified as distinct psychiatric conditions; however, they share overlapping symptoms and biological risk factors. Identifying molecular features that distinguish or unify these di...
Christie W Musket,Petra E Rupert,Susan S Kuo et al. Christie W Musket et al.
Background: Many individuals with schizophrenia have comorbid substance use disorders (SUD) and yet the reasons for this comorbidity are largely unknown. The current study examined if shared genetic effects jointly increa...
Wendy A Torrens,Jenna N Pablo,Marian E Berryhill et al. Wendy A Torrens et al.
Impaired auditory event-related potential (ERP) components, including the N100 and MMN, are linked to sensory signatures of schizophrenia. Nonclinical individuals with schizophrenia-like traits (schizotypy) provide an attractive model for i...